The "Weight" for a New Agent Is Almost Over: A Commentary on the Novel Triagonist Retatrutide for Obesity.
新藥的「重量」幾乎結束:關於新型三重拮抗劑 Retatrutide 用於肥胖的評論。
J Pharm Technol 2024-11-07
Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence.
發揮 retatrutide 的力量:可能戰勝肥胖和超重的一次勝利:一封通函。
Health Sci Rep 2024-02-10
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects.
Tirzepatide對2型糖尿病患者和非患者的體重減輕效果:功效和不良反應回顧。
Patient Prefer Adherence 2024-02-15
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity.
一項有關新型三重激動劑藥物 retatrutide 的評論,用於肥胖症治療。
Eur J Clin Pharmacol 2024-04-09